This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Early congressional investigations are planned on the subject of physician-ownership of pharmacies and drug-repackaging houses, physicians' dispensing of eyeglasses, and the cost of ethical drugs.The Senate antitrust subcommittee, headed by Sen. Thomas Hart (D, Mich) was expected to begin hearings late in January on the issue of physicians profiting from items they dispense. Hart held hearings in the last session on legislation that would forbid physicians or dentists from making profits on items they prescribe, but the bill was not acted on.A Senate Small Business Subcommittee is preparing for hearings in February on what chairman Gaylord Nelson (D, Wis) described as the "exorbitant" prices manufacturers set on drugs. Focus of the hearings was expected to be on the cost of drugs to the government.
Rep. John Fogarty (D, RI) an influential Congressman in the health field, died in his Congressional office. He collapsed about two
WASHINGTON NEWS. JAMA. 1967;199(4):23–24. doi:10.1001/jama.1967.03120040011003
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: